Evidence map›Paper›PMID 38737746›Full record

ArticlePeerJ2024

Regulation of cellular and molecular markers of epithelial-mesenchymal transition by Brazilin in breast cancer cells.

Lorena Cayetano-Salazar, Jose A Hernandez-Moreno, Jorge Bello-Martinez, Monserrat Olea-Flores, Eduardo Castañeda-Saucedo, Monica Ramirez, Miguel A Mendoza-Catalán, Napoleon Navarro-Tito

Abstract read
In one paragraph

Article in PeerJ, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lorena Cayetano-SalazarFacultad de Ciencias Químico Biológicas, Autonomous University of Guerrero, Chilpancingo, Guerrero, Mexico.
Jose A Hernandez-MorenoFacultad de Ciencias Químico Biológicas, Autonomous University of Guerrero, Chilpancingo, Guerrero, Mexico.
Jorge Bello-MartinezFacultad de Ciencias Químico Biológicas, Autonomous University of Guerrero, Chilpancingo, Guerrero, Mexico.
Monserrat Olea-FloresFacultad de Ciencias Químico Biológicas, Autonomous University of Guerrero, Chilpancingo, Guerrero, Mexico.ORCID 0000-0003-1813-9062
Eduardo Castañeda-SaucedoFacultad de Ciencias Químico Biológicas, Autonomous University of Guerrero, Chilpancingo, Guerrero, Mexico.ORCID 0000-0002-0669-4408
Monica RamirezFacultad de Ciencias Químico Biológicas, Autonomous University of Guerrero, Chilpancingo, Guerrero, Mexico.ORCID 0000-0001-5386-8530
Miguel A Mendoza-CatalánFacultad de Ciencias Químico Biológicas, Autonomous University of Guerrero, Chilpancingo, Guerrero, Mexico.ORCID 0000-0002-6247-8590
Napoleon Navarro-TitoFacultad de Ciencias Químico Biológicas, Autonomous University of Guerrero, Chilpancingo, Guerrero, Mexico.ORCID 0000-0003-4911-0545

Funding

COCYTIEGSEP-CONACYT
6 · The paper itself

Abstract

Breast cancer is the most common invasive neoplasm and the leading cause of cancer death in women worldwide. The main cause of mortality in cancer patients is invasion and metastasis, where the epithelial-mesenchymal transition (EMT) is a crucial player in these processes. Pharmacological therapy has plants as its primary source, including isoflavonoids. Brazilin is an isoflavonoid isolated from

Indexed as

BenzopyransBreast NeoplasmsCadherinsEpithelial-Mesenchymal TransitionCell Line, TumorFemaleHumansMatrix MetalloproteinasesMCF-7 CellsNeoplasm InvasivenessNuclear ProteinsTriple Negative Breast NeoplasmsTwist-Related Protein 1VimentinBenzopyransbrazilinCadherinsMatrix MetalloproteinasesNuclear ProteinsTWIST1 protein, humanTwist-Related Protein 1VimentinBrazilinBreast cancerCell invasionE-cadherinMMP-2MMP-9Vimentin

Identifiers

PMID38737746
PMCPMC11088821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.